1,659
Views
26
CrossRef citations to date
0
Altmetric
Report

GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment

, , , , , , , , , & show all
Pages 1125-1133 | Received 08 Jan 2016, Accepted 18 Feb 2016, Published online: 07 Mar 2016

References

  • Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19:1423-37; PMID:24202395; http://dx.doi.org/10.1038/nm.3394
  • Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49:6449-65; PMID:2684393
  • Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Seminars Radiation Oncol 2004; 14:198-206; PMID:15254862; http://dx.doi.org/10.1016/j.semradonc.2004.04.008
  • Amend SR, Pienta KJ. Ecology meets cancer biology: The cancer swamp promotes the lethal cancer phenotype. Oncotarget 2015; 6:9669-78; PMID:25895024; http://dx.doi.org/10.18632/oncotarget.3430
  • Engin K, Leeper DB, Cater JR, Thistlethwaite A J, Tupchong L, McFarlane JD. Extracellular pH distribution in human tumours. Int J Hyperthermia 1995; 11:211-6; PMID:7790735; http://dx.doi.org/10.3109/02656739509022457
  • Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996; 56:1194-8; PMID:8640796
  • Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3:177-82; PMID:9018236; http://dx.doi.org/10.1038/nm0297-177
  • Williams AC, Collard TJ, Paraskeva C. An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene 1999; 18:3199-204; PMID:10359525; http://dx.doi.org/10.1038/sj.onc.1202660
  • Morita T, Nagaki T, Fukuda I, Okumura K. Clastogenicity of low pH to various cultured mammalian cells. Mutation Res 1992; 268:297-305; PMID:1379335; http://dx.doi.org/10.1016/0027-5107(92)90235-T
  • Leontieva OV, Blagosklonny MV. Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression. Aging (Albany NY) 2011; 3:1078-91; PMID:22156391
  • Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 1996; 14:176-86; PMID:8605731; http://dx.doi.org/10.1007/BF00121214
  • Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006; 66:6699-707; PMID:16818644; http://dx.doi.org/10.1158/0008-5472.CAN-06-0983
  • Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009; 69:2260-8; PMID:19276390; http://dx.doi.org/10.1158/0008-5472.CAN-07-5575
  • Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharmaceutics 2011; 8:2032-8; PMID:21981633; http://dx.doi.org/10.1021/mp200292c
  • Estrella V, Chen T, Lloyd M, Wojtkowiak J¸, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 2013; 73:1524-35; PMID:23288510; http://dx.doi.org/10.1158/0008-5472.CAN-12-2796
  • Gupta SC, Singh R, Pochampally R, Watabe, K, Mo YY. Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-kappaB pathway. Oncotarget 2014; 5:12070-82; PMID:25504433; http://dx.doi.org/10.18632/oncotarget.2514
  • Peppicelli S, Bianchini F, Toti A, Laurenzana A, Fibbi G, Calorini L. Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression. Cell cycle 2015; 14:3088-100; PMID:26496168; http://dx.doi.org/10.1080/15384101.2015.1078032
  • Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011; 11:671-7; PMID:21833026; http://dx.doi.org/10.1038/nrc3110
  • Wojtkowiak JW, Rothberg JM, Kumar V, Schramm KJ, Haller E, Proemsey JB, Lloyd MC, Sloane BF, Gillies RJ. Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 2012; 72:3938-47; PMID:22719070; http://dx.doi.org/10.1158/0008-5472.CAN-11-3881
  • Marino ML, Pellegrini P, Di Lernia G, Djavaheri-Mergny M, Brnjic S, Zhang X, Hagg M, Linder S, Fais S, Codogno P, et al. Autophagy is a protective mechanism for human melanoma cells under acidic stress. J Biol Chem 2012; 287:30664-76; PMID:22761435; http://dx.doi.org/10.1074/jbc.M112.339127
  • Lamonte G, Tang X, Chen JL, Wu J, Ding CK, Keenan MM, Sangokoya C, Kung HN, Ilkayeva O, Boros LG, et al. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer Metab 2013; 1:23; PMID:24359630; http://dx.doi.org/10.1186/2049-3002-1-23
  • Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192:1-15; PMID:12115731; http://dx.doi.org/10.1002/jcp.10119
  • Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012; 48:158-67; PMID:23102266; http://dx.doi.org/10.1016/j.molcel.2012.09.025
  • Xu B, Wang W, Guo H, Sun Z, Wei Z, Zhang X, Liu Z, Tischfield JA, Gong Y, Shao C. Oxidative stress preferentially induces a subtype of micronuclei and mediates the genomic instability caused by p53 dysfunction. Mutation Res 2014; 770:1-8; PMID:25302047; http://dx.doi.org/10.1016/j.mrfmmm.2014.08.004
  • Wei Z, Guo H, Liu Z, Zhang X, Liu Q, Qian Y, Gong Y, Shao C. CUL4B impedes stress-induced cellular senescence by dampening a p53-reactive oxygen species positive feedback loop. Free Radical Biol Med 2015; 79:1-13; PMID:25464270; http://dx.doi.org/10.1016/j.freeradbiomed.2014.11.010
  • Seo Y, Kinsella TJ. Essential role of DNA base excision repair on survival in an acidic tumor microenvironment. Cancer Res 2009; 69:7285-93; PMID:19723658; http://dx.doi.org/10.1158/0008-5472.CAN-09-0624
  • Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8:579-91; PMID:19478820; http://dx.doi.org/10.1038/nrd2803
  • Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 2013; 12:931-47; PMID:24287781; http://dx.doi.org/10.1038/nrd4002
  • Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA, et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 2015; 27:211-22; PMID:25620030; http://dx.doi.org/10.1016/j.ccell.2014.11.019
  • Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994; 269:9397-400; PMID:8144521
  • Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(−) and thereby promotes tumor growth. Cancer Cell 2011; 19:387-400; PMID:21397861; http://dx.doi.org/10.1016/j.ccr.2011.01.038
  • Gaedcke J, Grade M, Jung K, Camps J, Jo P, Emons G, Gehoff A, Sax U, Schirmer M, Becker H, et al. Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer 2010; 49:1024-34; PMID:20725992; http://dx.doi.org/10.1002/gcc.20811
  • White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012; 12:401-10; PMID:22534666; http://dx.doi.org/10.1038/nrc3262
  • Liu Q, Xu X, Zhao M, Wei Z, Li X, Zhang X, Liu Z, Gong Y, Shao C. Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway. Mol Cancer Therapeutics 2015; 14:355-63; PMID:25504754; http://dx.doi.org/10.1158/1535-7163.MCT-14-0634